State Street Corp increased its position in Imperva Inc (NYSE:IMPV) by 2.6% during the first quarter, Holdings Channel reports. The institutional investor owned 532,533 shares of the software maker’s stock after buying an additional 13,390 shares during the period. State Street Corp’s holdings in Imperva were worth $21,859,000 at the end of the most recent quarter.

Other hedge funds also recently bought and sold shares of the company. BNP Paribas Arbitrage SA boosted its stake in Imperva by 8,392.3% in the first quarter. BNP Paribas Arbitrage SA now owns 200,927 shares of the software maker’s stock worth $8,248,000 after buying an additional 198,561 shares in the last quarter. Bank of New York Mellon Corp boosted its stake in Imperva by 1.9% in the first quarter. Bank of New York Mellon Corp now owns 125,398 shares of the software maker’s stock worth $5,148,000 after buying an additional 2,295 shares in the last quarter. US Bancorp DE boosted its stake in Imperva by 142.3% in the first quarter. US Bancorp DE now owns 5,386 shares of the software maker’s stock worth $221,000 after buying an additional 3,163 shares in the last quarter. Capital Fund Management S.A. bought a new stake in Imperva during the first quarter worth approximately $2,520,000. Finally, First Trust Advisors LP boosted its stake in Imperva by 35.2% in the first quarter. First Trust Advisors LP now owns 154,591 shares of the software maker’s stock worth $6,346,000 after buying an additional 40,263 shares in the last quarter. Hedge funds and other institutional investors own 92.72% of the company’s stock.

Imperva Inc (NYSE IMPV) traded up 1.75% during trading on Friday, hitting $43.60. The stock had a trading volume of 730,246 shares. The company has a 50 day moving average of $47.61 and a 200-day moving average of $45.32. Imperva Inc has a 12-month low of $34.40 and a 12-month high of $57.24. The company’s market cap is $1.47 billion.

Imperva (NYSE:IMPV) last issued its earnings results on Thursday, July 27th. The software maker reported ($0.10) earnings per share for the quarter, missing the consensus estimate of $0.05 by $0.15. Imperva had a negative return on equity of 5.00% and a negative net margin of 4.69%. The firm had revenue of $74.44 million during the quarter, compared to analyst estimates of $74.30 million. During the same period in the previous year, the company earned ($0.23) earnings per share. The business’s revenue for the quarter was up 28.6% on a year-over-year basis. On average, equities analysts predict that Imperva Inc will post $0.81 EPS for the current year.

ILLEGAL ACTIVITY NOTICE: This report was posted by Watch List News and is the sole property of of Watch List News. If you are accessing this report on another site, it was illegally stolen and republished in violation of United States and international trademark and copyright laws. The legal version of this report can be viewed at https://www.watchlistnews.com/state-street-corp-buys-13390-shares-of-imperva-inc-impv/1482226.html.

A number of research firms recently commented on IMPV. Stifel Nicolaus reiterated a “hold” rating and set a $47.00 price objective on shares of Imperva in a research report on Friday, July 14th. Susquehanna Bancshares Inc began coverage on Imperva in a research report on Wednesday, June 7th. They set a “positive” rating and a $60.00 price objective for the company. UBS AG began coverage on Imperva in a research report on Tuesday, June 6th. They set a “positive” rating and a $60.00 price objective for the company. Stephens reiterated an “overweight” rating and set a $61.00 price objective (up previously from $53.00) on shares of Imperva in a research report on Thursday, July 13th. Finally, BidaskClub cut Imperva from a “buy” rating to a “hold” rating in a research report on Tuesday, July 25th. Two analysts have rated the stock with a sell rating, seven have given a hold rating, twelve have assigned a buy rating and one has issued a strong buy rating to the stock. The stock presently has a consensus rating of “Buy” and a consensus price target of $51.25.

In other Imperva news, insider Amichai Shulman sold 3,089 shares of the company’s stock in a transaction dated Monday, May 15th. The stock was sold at an average price of $48.70, for a total value of $150,434.30. Following the transaction, the insider now directly owns 100,151 shares of the company’s stock, valued at approximately $4,877,353.70. The sale was disclosed in a legal filing with the SEC, which is accessible through the SEC website. Also, SVP Sunil D. Nagdev sold 4,857 shares of the company’s stock in a transaction dated Tuesday, May 16th. The stock was sold at an average price of $49.00, for a total value of $237,993.00. Following the completion of the transaction, the senior vice president now directly owns 16,290 shares in the company, valued at $798,210. The disclosure for this sale can be found here. Corporate insiders own 2.20% of the company’s stock.

About Imperva

Imperva, Inc provides cyber-security solutions that protect business-critical data and applications whether in the cloud or on premises. The Company is engaged in the development, marketing, sales, service and support of cyber-security solutions. The Company’s products include its Imperva SecureSphere Paltform, Imperva CounterBreach and Imperva Camouflage for enterprise data centers, and Imperva Incapsula offering for cloud-based security services.

Want to see what other hedge funds are holding IMPV? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Imperva Inc (NYSE:IMPV).

Institutional Ownership by Quarter for Imperva (NYSE:IMPV)

Receive News & Ratings for Imperva Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Imperva Inc and related companies with Analyst Ratings Network's FREE daily email newsletter.